MVolution Partners

MVolution Partners is a private equity firm based in the United States, established in 2021. The company operates under remote-first principles, allowing it to leverage a flexible work environment. MVolution Partners focuses its investments on the healthcare technology sector, aiming to identify and support innovative companies that are poised to advance the industry. Through its strategic approach, the firm seeks to create value and drive growth in its portfolio companies within this dynamic market.

Michael Weinmann

Co-Founding Partner

4 past transactions

Pragmatic Semiconductor

Series D in 2023
Pragmatic specializes in ultra-low-cost flexible electronics. Its FlexICs, thinner than human hair, enable innovative solutions by embedding circuits invisibly into objects. The company offers a FlexIC Foundry service for custom application-specific devices and standard FlexIC products for mass market use cases like RFID and NFC. Pragmatic's revolutionary FlexLogIC production system facilitates high-volume manufacturing at significantly lower costs compared to traditional silicon IC fabs. Headquartered in Cambridge, UK, with a billion-unit production facility in Sedgefield, the company serves diverse markets such as consumer goods, retail, healthcare, and gaming.

PainTEQ

Debt Financing in 2023
PainTEQ specializes in developing and delivering solutions for the interventional pain management sector. The company focuses on creating joint implants and offering procedures aimed at treating back pain and sacroiliac (SI) fusion, with a commitment to minimally invasive treatments.

Pixelligent Technologies

Debt Financing in 2022
Pixelligent Technologies develops and manufactures optical materials, including nanocrystal dispersions and polymer nanocomposites, for solid-state lighting, displays, and optical coatings. Its PixClearProcess platform enables engineering of PixClear materials to integrate into common manufacturing methods such as inkjet, nanoimprint, spin coating, dispensing, slot-dye, and photolithography. The company offers zirconia nanocrystal dispersions, high-refractive-index zirconia-silicone nanocomposites, and customized dispersions for prototype applications, along with starter kits to help customers identify suitable products. It serves lighting and electronics markets worldwide, including LED and OLED lighting, and maintains a strategic collaboration with Corning Incorporated. Founded in 2000 and based in Baltimore, Maryland.

Pathware

Series A in 2022
Pathware is a technology company developing a digital pathology platform for point-of-care diagnostics. The platform combines computational microscopy and artificial intelligence to analyze tissue samples, enabling clinicians and pathologists to diagnose and treat diseases earlier and more precisely, with the goal of improving patient outcomes and reducing diagnostic times. Its product set includes Bioptic, an automated point-of-care biopsy assessment system, along with a sample testing platform and a sample management platform designed to streamline pathology workflows. Founded in 2017 and based in Ann Arbor, Michigan, with an additional location in Seattle, Pathware focuses on bringing computational pathology tools to the bedside to support faster, more accurate decision making in healthcare.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.